MedTrace Logo

Effectiveness of Fustra-Exercise Program in Neck and Low Back Pain

NCT02235207 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2016-03-11

No results posted yet for this study

Summary

The purpose of the study is to investigate the effectiveness of Fustra® exercise program in relieving recurrent pain in the neck or/and back, and thus improve quality of life in female and male office workers. The hypothesis is that neuromuscular exercise will improve control of posture and movement, neck shoulder and trunk flexibility, trunk muscular endurance and leg strength, and thus decrease intensity of pain by 30% compared to non-exercise group. In addition, financial feasibility of the exercise program and effects of training on quality of life and perceived work ability are studied.

Conditions

  • Neck Pain
  • Low Back Pain, Recurrent

Interventions

BEHAVIORAL

Neuromuscular exercise

Fustra20 Neck \& Back is individually guided, graded neuromuscular exercise program which is conducted twice a week for 20 times. Each session lasts one hour. After 20 sessions participants are encouraged to continue exercising at home with a help of an individual home exercise plan including diary of compliance. The main targets are to * improve movement control in different posture and movements of the neck and back * improve flexibility with active functional movements * improve pelvic, spine and shoulder-neck stability using co-contraction of several muscle groups, and thus enhancing gross movement of the whole kinetic chain * improve muscular endurance of shoulder neck area, trunk, pelvis and lower extremities

Sponsors & Collaborators

  • Fustra International Oy

    collaborator UNKNOWN

  • UKK Institute

    lead OTHER

Principal Investigators

  • Jaana H Suni, PhD · UKK Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02235207 on ClinicalTrials.gov